Kotak Healthcare Fund
The fund maintains a heavily concentrated pharmaceutical focus, with over 71% in drugs and biotech while hospitals command just over a quarter of the portfolio. Sun Pharma's outsized 14% position signals conviction in large-cap stability, though the top ten stocks consuming 57% of assets suggests limited diversification within the healthcare theme. Recent additions of diagnostic players and Mankind Pharma's increased weight indicate the manager is broadening exposure toward higher-growth segments while trimming larger-cap pharma exposure, reflecting cautious optimism on mid-tier healthcare franchises.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| Direct Growth | ₹15.2750 | — | — | — | — | — | — |
| Regular Growth | ₹14.6800 | +9.97% | +10.45% | +7.51% | +12.81% | — | — |
| Direct IDCW | ₹15.2730 | — | — | — | — | — | — |
| Regular IDCW | ₹14.6850 | — | — | — | — | — | — |
Portfolio Metrics(latest month)
What Changed2026-03-31 → 2026-04-30
| Stock | Weight |
|---|---|
| DR.Lal Pathlabs Ltd | 1.21% |
| METROPOLIS HEALTHCARE LTD. | 0.76% |
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LTD. INE044A01036 | 14.04% |
| 2 | JB Chemicals & Pharmaceuticals Ltd. INE572A01036 | 6.63% |
| 3 | Max Healthcare Institute Ltd. INE027H01010 | 6.31% |
| 4 | Divis Laboratories Ltd. INE361B01024 | 5.90% |
| 5 | Fortis Healthcare India Ltd INE061F01013 | 4.84% |
| 6 | Ami Organics Ltd INE00FF01025 | 4.60% |
| 7 | Cipla Ltd. INE059A01026 | 4.22% |
| 8 | PARK MEDI WORLD LIMITED (PARK HOSPITAL) INE119201023 | 3.79% |
| 9 | KRISHNA INSTITUTE OF MEDICAL INE967H01025 | 3.56% |
| 10 | Apollo Hospitals Enterprise Ltd. INE437A01024 | 3.08% |
| 11 | Lupin Ltd. INE326A01037 | 3.02% |
| 12 | SAI LIFE SCIENCES LIMITED INE570L01029 | 3.02% |
| 13 | MANKIND PHARMA LTD INE634S01028 | 2.72% |
| 14 | Aurobindo Pharma Ltd. INE406A01037 | 2.64% |
| 15 | JUBILANT PHARMOVA LIMITED INE700A01033 | 2.52% |
| 16 | ANTHEM BIOSCIENCES LTD INE0CZ201020 | 2.45% |
| 17 | Glenmark Pharmaceuticals Ltd INE935A01035 | 2.43% |
| 18 | Ajanta Pharma Ltd. INE031B01049 | 2.39% |
| 19 | Alkem Laboratories Ltd. INE540L01014 | 2.07% |
| 20 | RUBICON RESEARCH LIMITED INE506V01022 | 1.96% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.